12305 related articles for article (PubMed ID: 11592301)
21. Aneurysmal dermatofibroma mimicking both clinical and dermoscopic malignant melanoma and Kaposi's sarcoma.
Morariu SH; Suciu M; Vartolomei MD; Badea MA; Cotoi OS
Rom J Morphol Embryol; 2014; 55(3 Suppl):1221-4. PubMed ID: 25607410
[TBL] [Abstract][Full Text] [Related]
22. Knowledge of malignant melanoma and how it relates to clinical practice among nurse practitioners and dermatology and oncology nurses.
Maguire-Eisen M; Frost C
Cancer Nurs; 1994 Dec; 17(6):457-63. PubMed ID: 7820823
[TBL] [Abstract][Full Text] [Related]
23. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.
Topalian SL; Muul LM; Solomon D; Rosenberg SA
J Immunol Methods; 1987 Aug; 102(1):127-41. PubMed ID: 3305708
[TBL] [Abstract][Full Text] [Related]
24. [Grenz ray therapy].
Lindelöf B
Hautarzt; 1989 Jan; 40(1):4-7. PubMed ID: 2646248
[TBL] [Abstract][Full Text] [Related]
25. The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells.
Chopra H; Timar J; Chen YQ; Rong XH; Grossi IM; Fitzgerald LA; Taylor JD; Honn KV
Int J Cancer; 1991 Nov; 49(5):774-86. PubMed ID: 1937964
[TBL] [Abstract][Full Text] [Related]
26. Cell binding and tumor inhibiting functions of a new antihuman melanoma murine monoclonal antibody.
Abdel-Wahab Z; Darrow T; Vervaert CE; Crowley NJ; Seigler HF
Mol Biother; 1991 Sep; 3(3):163-9. PubMed ID: 1768367
[TBL] [Abstract][Full Text] [Related]
27. Selective growth inhibition of a human malignant melanoma cell line by sesame oil in vitro.
Smith DE; Salerno JW
Prostaglandins Leukot Essent Fatty Acids; 1992 Jun; 46(2):145-50. PubMed ID: 1502251
[TBL] [Abstract][Full Text] [Related]
28. Linkage mapping of melanoma (MLM) using 172 microsatellite markers.
Nancarrow DJ; Walker GJ; Weber JL; Walters MK; Palmer JM; Hayward NK
Genomics; 1992 Dec; 14(4):939-47. PubMed ID: 1478674
[TBL] [Abstract][Full Text] [Related]
29. Diffuse melanosis and trichochromuria in malignant melanoma.
Agrup G; Agrup P; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1979; 59(5):456-7. PubMed ID: 93371
[TBL] [Abstract][Full Text] [Related]
30. [Primary melanoma of the esophagus].
Cardeña R; Yep-Gamarra V; Donet-Mostacero J; Rodas J
Rev Gastroenterol Peru; 2012; 32(3):303-8. PubMed ID: 23128952
[TBL] [Abstract][Full Text] [Related]
31. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort.
Freedman DM; Sigurdson A; Doody MM; Rao RS; Linet MS
Cancer Causes Control; 2003 Nov; 14(9):847-57. PubMed ID: 14682442
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells: controllers of the immune system and a new promise for immunotherapy.
Banchereau J; Fay J; Pascual V; Palucka AK
Novartis Found Symp; 2003; 252():226-35; discussion 235-8, 257-67. PubMed ID: 14609222
[TBL] [Abstract][Full Text] [Related]
33. Surgical and molecular approaches to the sentinel lymph nodes.
Essner R; Kojima M
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):31S-34S. PubMed ID: 11599894
[TBL] [Abstract][Full Text] [Related]
34. Secretion of both IL-2 and IL-4 by tumor cells results in rejection and immunity.
Strome SE; Chang AE; Shu S; Krauss JC
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):21-32. PubMed ID: 9147701
[TBL] [Abstract][Full Text] [Related]
35. Benign clear cell thyroid tumor with "balloon cell" change: evidence suggesting its pathogenesis.
Sobel HJ; Lamovec J; Us-Krasovec M; Zitnik V
Ultrastruct Pathol; 1993; 17(3-4):469-75. PubMed ID: 8266606
[TBL] [Abstract][Full Text] [Related]
36. Perspectives of cytokine treatment in malignant skin tumors.
Garbe C
Recent Results Cancer Res; 1995; 139():349-69. PubMed ID: 7597303
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity and toxicity of cisplatin analogs.
Rose WC; Schurig JE; Huftalen JB; Bradner WT
Cancer Treat Rep; 1982 Jan; 66(1):135-46. PubMed ID: 7198010
[No Abstract] [Full Text] [Related]
38. Malignant melanoma: sister chromatid exchange analysis in three families.
Ghidoni A; Privitera E; Raimondi E; Rovini D; Illeni MT; Cascinelli N
Cancer Genet Cytogenet; 1983 Aug; 9(4):347-54. PubMed ID: 6871839
[TBL] [Abstract][Full Text] [Related]
39. Repair of facial defects with advancement-rotation flaps.
Lawson VG
J Otolaryngol; 1983 Aug; 12(4):246-8. PubMed ID: 6620450
[TBL] [Abstract][Full Text] [Related]
40. Low-molecular-weight membrane component inhibits the metastatic phenotype of B16-F10 melanoma.
Keren Z; LeGrue SJ
Clin Exp Metastasis; 1989; 7(3):315-28. PubMed ID: 2924448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
